15 Nov 2022 --- The US-based Council for Responsible Nutrition (CRN) recently issued a damning statement regarding an AstraZeneca-funded study which compared the cholesterol-lowering effects of six different supplements to the statin drug Rosuvastatin, claiming that the study was potentially biased. The accusation was based on CRN’s interpretation that the study was not double-blind and therefore lacks validity. Additionally, the organization holds that the selection of supplements used along with the timespan of the study may give people a false impression about the efficacy of supplements.
